↓ Skip to main content

Norcantharidin ameliorates estrogen deficient-mediated bone loss by attenuating the activation of extracellular signal-regulated kinase/ROS/NLRP3 inflammasome signaling

Overview of attention for article published in Frontiers in Pharmacology, November 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
2 Mendeley